BALTIMORE (KMOX) – As a result of a packaging error, oral contraceptive tablets were placed out of sequence, and may place the user at risk for contraceptive failure and unintended pregnancy. The Mibelas 24 Fe birth control tablets are distributed nationally by Lupin Pharmaceuticals.
The packages were “rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible.”
The four non-hormonal placebo tablets were put in the wrong position, at the beginning of the sequence, pushing the active tablets back.
“As a result of this packaging error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy,” reports the U.S. Food & Drug Administration.
Lupin’s produces brands such as: Methylphenidate HCI, Alinia, InspiraChamber, Antara 90mg, and Suprax.
Lupin is notifying its distributors and customers by recall letter and is arranging for return of all recalled products. Consumers who have the affected product should notify their physician and return the product to the pharmacy or place of purchase.
Consumers with questions regarding this recall can contact Lupin by phone 1-800-399-2561, 8:00 am to 5:00 pm EST, Monday through Friday.